## Table 2 |
||||||||||

Different expression of c-Jun, N-ras, Caspase9 and p73 in different clinical stages
of thymoma n (%) |
||||||||||

Stage I N = 21 |
Stage II N = 20 |
Stage III N = 15 |
Stage IV N = 4 |
Total N = 60 |
P^{a} |
P^{b} |
P^{c} |
P^{d} |
||

C-Jun |
+ |
6 (28.6) | 4 (20.0) | 8 (53.3) | 4 (100.0) | 22 (36.7) | 0.009 |
0.004 |
0.523 | 0.245 |

N-ras |
+ |
3 (14.3) | 3 (15.0) | 6 (40.0) | 0 (0) | 12 (20.0) | 0.184 | |||

Caspase9 |
+ |
8 (38.1) | 11 (55.0) | 8 (53.3) | 3 (75.0) | 30 (50.0) | 0.482 | |||

p73 |
+ |
6 (28.6) | 10 (50.0) | 9 (60.0) | 3 (75.0) | 28(46.6) | 0.089 |

*P*^{a}: Two-sided Fisher’s exact test for distributions between different stages of TETs.

*P*^{b}: Two-sided Fisher’s exact test for distributions between stage III + IV and stage
I + II of TETs.

*P*^{c}: Two-sided Fisher’s exact test for distributions between stage I and stage II of
TETs.

*P*^{d}: Two-sided Fisher’s exact test for distributions between stage III and stage IV of
TETs.

Ma * et al.*

Ma * et al.* *Diagnostic Pathology* 2012 **7**:120 doi:10.1186/1746-1596-7-120